Value-based oncology care requires balancing rapid innovation with operational sustainability, equitable access, and ...

Radiomics offers improved assessment of spinal cord pathology in MS, surpassing conventional MRI in precision and sensitivity ...

1. Garg S, Donnenfeld E, Sheppard J, Epitropoulos A, Brady TC. Reproxalap improves ocular redness, tear production, and ...

Panelists explain that in the absence of head-to-head trial data, real-world evidence (RWE) becomes crucial in guiding ...

Panelists discuss how real-world outcomes inform patient conversations and support shared decision-making for third-line ...

Mutations in ZRSR2 have been linked with disease progression in patients with JAK2 V617R – driven myeloproliferative ...

Amid rapid advances in oncology, barriers such as treatment costs, health inequities, and clinician burnout remain critical challenges, as highlighted by experts at a regional Institute for ...

CKD and VHD share metabolic, inflammatory, and fibrotic pathways, worsening each other's progression and complicating ...

Amid a government shutdown in nearby Washington, DC, Paul Ryan, former speaker of the House, told attendees at the Academy of ...

Olfactory dysfunction in MS may be linked to nasal microbial changes, not just central inflammation. MS patients showed lower ...

The multidisciplinary RA care pathway achieved higher remission rates and faster disease control than usual care, despite more severe baseline conditions. The pathway's interdisciplinary model ...

In a 2025 qualitative analysis of payer insights conducted by McKesson and Lumanity, 20 payers representing nearly 280 million covered lives reported that although they broadly view CGTs as safe (90%) ...